IHEC-associated project BLUEPRINT delivers beyond expectation: BLUEPRINT study of epigenetics of blood will serve biology and medicine
Researchers from the EU-funded BLUEPRINT project join their international colleagues this week at the 2016 International Human Epigenome Consortium (IHEC) conference in Brussels to report the latest results in understanding blood cell development and blood disease.
Following the IHEC meeting on 7 September, the conference held in Brussels on 8-9 September 2016 marks the final stage of the BLUEPRINT project. “BLUEPRINT has produced more new science and more understanding of blood cell disease than we could have imagined at the outset,” says BLUEPRINT coordinator Professor Hendrik (Henk) Stunnenberg from Radboud University, Nijmegen, The Netherlands. “We have forged an alliance of researchers and innovative companies from around Europe and, working closely with international partners, we already see results that, in time, will improve the lives of patients. I’ve been honoured to coordinate such a diligent, creative and effective group, who have delivered beyond all expectation.”
Find the full press release and media kit here.